[HTML][HTML] Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases–A position paper from the International Lipid …

M Ruscica, PE Penson, N Ferri, CR Sirtori… - Progress in …, 2021 - Elsevier
Inflammation is a marker of arterial disease stemming from cholesterol-dependent to-
independent molecular mechanisms. In recent years, the role of inflammation in …

[HTML][HTML] RNA silencing in the management of dyslipidemias

NC Henney, M Banach, PE Penson - Current atherosclerosis reports, 2021 - Springer
Abstract Purpose of Review Remarkable reductions in cardiovascular morbidity and
mortality have been achieved in recent decades through the widespread use of 'small …

Effect of the renin-angiotensin system inhibitors on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials

K Awad, MM Zaki, M Mohammed, J Lewek… - Mayo Clinic …, 2022 - Elsevier
Objective To synthesize more conclusive evidence on the anti-inflammatory effects of
angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers …

[HTML][HTML] Repurposing drugs to treat cardiovascular disease in the era of precision medicine

M Abdelsayed, EJ Kort, S Jovinge… - Nature Reviews …, 2022 - nature.com
Drug repurposing is the use of a given therapeutic agent for indications other than that for
which it was originally designed or intended. The concept is appealing because of …

Efficacy and safety of colchicine in patients with coronary artery disease: a systematic review and meta‐analysis of randomized controlled trials

I Bytyci, G Bajraktari, PE Penson… - British Journal of …, 2022 - Wiley Online Library
Aims Inflammation plays a central role in the pathogenesis and clinical manifestations of
atherosclerosis. Randomized controlled trials have investigated the potential benefit of …

Emerging Insights into Pyrazoline Motifs: A Comprehensive Exploration of Biological Mechanisms and Prospects for Future Advancements

HA Abou-Zied, EAM Beshr, AM Hayallah… - Journal of Molecular …, 2023 - Elsevier
The prevalence of cancer and neurodegenerative diseases, such as Alzheimer's and
Parkinson's, continues to rise worldwide, presenting a significant health burden. Despite …

[HTML][HTML] Nutraceuticals for the control of dyslipidaemias in clinical practice

PE Penson, M Banach - Nutrients, 2021 - mdpi.com
Dyslipidaemias result in the deposition of cholesterol and lipids in the walls of blood vessels,
chronic inflammation and the formation of atherosclerotic plaques, which impede blood flow …

New Benzoazepine Alkaloids of Colchicum speciosum

AAS Parvaneh, D Habibi, F Arezi, MM Gilan - Chemistry of Natural …, 2024 - Springer
The object of this research was isolation of the two new benzoazepine alkaloids–3, 10, 11,
12-tetramethoxy-4-oxo-7, 8-dihydrobenzo [d] cyclohepta [b] azepine-6 (4H)-carbaldehyde …

[PDF][PDF] Питание в коррекции дислипидемии

АВ Погожева, СА Дербенева - 2022 - publishing.intelgr.com
В монографии представлены современные механизмы формирования
кардиоваскулярной патологии. Большое внимание уделяется дислипидемии как …

Is colchicine the holy grail for treating inflammation and reducing cardiovascular risk?

KJ Filipiak, S Surma - International Journal of cardiology …, 2021 - ncbi.nlm.nih.gov
[1] M. Tomaniak, KJ Filipiak, Anti-inflammatory therapy in the treatment of cardiovascular
diseases, Kardiol. Pol. 73 (12)(2015) 1295–1303, https://doi. org/10.5603/KP. a2015. 0191 …